NCT04521179dual-epitope blocking anti-human epidermal growth factor receptor 2 antibodycytotoxic T-lymphocyte-associated protein 4/programmed death-ligand 1 bispecific antibodytreatment-resistant metastatic breast cancer
…ue in evaluating treatment responses. Trial registration number NCT04521179.…